United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-7521_48d58ab4-2d5c-4ac2-a2f3-a8b5163f0f28
- Product NDC
- 50090-7521
- Form
- TABLET
- Composition / generic term
- Levetiracetam
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230501
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (50090-7521-0) · 50090-7521-0
- 60 TABLET in 1 BOTTLE (50090-7521-1) · 50090-7521-1
- 90 TABLET in 1 BOTTLE (50090-7521-2) · 50090-7521-2
- 180 TABLET in 1 BOTTLE (50090-7521-3) · 50090-7521-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →